Community Action Needed: Please respond to the NIH RFI
OBO ID: CHEBI:5147
Term Name: formoterol Search Ontology:
Synonyms:
  • (+-)-2'-hydroxy-5'-((RS)-1-hydroxy-2-(((RS)-p-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide
  • (+-)-formoterol
  • (R*,R*)-(+-)-N-[2-hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide
  • formoterol
  • formoterolum
  • N-{2-hydroxy-5-[(1RS)-1-hydroxy-2-{[(2RS)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide
  • rac-N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide
Definition: A racemate consisting of equal amounts of arformoterol (the active enantiomer) and (S,S)-formoterol (the inactive enantiomer). Its fumaric acid salt is used as a direct-acting sympathomimetic and bronchodilator for the treatment of chronic obstructive pulmonary disease (any progressive respiratory disease that makes it harder to breathe over time, such as chronic bronchitis and emphysema).
References:
  • CAS:73573-87-2
  • DrugBank:DB00983
  • KEGG:C07805
  • KEGG:D07990
  • Patent:DE2305092
  • Patent:US3994974
  • Reaxys:6741801
  • Wikipedia:Formoterol
Ontology: Chebi
PHENOTYPE No data available